Revolutionizing Alzheimer’s Disease Diagnosis and Treatment: Theranostic Approaches

Alzheimer’s Disease Theranostics, a pioneering work by Magisetty Obulesu, delves into the latest advancements in theranostic avenues for diagnosing and treating Alzheimer’s disease. This comprehensive guide explores the dual benefits of nanoparticles in crossing the blood-brain barrier and alleviating disease symptoms, highlighting both the advantages and disadvantages of this approach.

In spite of the complexities of drug delivery to the brain, nanoparticulate platforms have shown promising results in combating neurodegenerative disorders such as Alzheimer’s. This book examines a wide range of theranostic applications, including:

• Antioxidants: harnessing their potential in Alzheimer’s disease treatment
• Natural bioactive compounds: their role in alleviating disease symptoms
• Gene therapy: a cutting-edge approach to tackle Alzheimer’s
• Nanotechnological approaches: innovative solutions for diagnosis and treatment

The author provides a thorough analysis of nanoparticle therapeutics, addressing common challenges and sharing valuable lessons learned from blood-brain barrier challenges, viral vector approaches, and mitochondria-targeted therapeutics.

Key Features

• Comprehensive overview of nanoparticle therapeutics for Alzheimer’s disease
• In-depth exploration of antioxidant applications
• Expert analysis of common challenges and lessons learned in theranostic research

With its unique blend of academic rigor and practical insights, Alzheimer’s Disease Theranostics is an indispensable resource for researchers, clinicians, and policymakers seeking to advance our understanding of this debilitating disease and develop effective treatment strategies.

Published by Elsevier Science in 2019, this seminal work is available in English and can be identified by the following ISBN numbers: 9780128164129 and 9780128167397.